This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Euclid Systems Corporation Signs Agreement With Wenzhou Medical University To Promote The Use Of Orthokeratology To Control Myopia Progression

HERNDON, Va., Sept. 11, 2013 /PRNewswire/ -- Euclid Systems Corporation today announced the signing of a cooperation agreement with Wenzhou Medical University Eye Hospital. 

"Thanks to a number of studies showing the ability of Euclid's Emerald™ brand Ortho-K lens to retard the progression (worsening) of myopia in children, the Chinese population are accepting this treatment in increasing numbers," stated Michael A Ross, MD, President and COO of Euclid.  "This strategic partnership with the Wenzhou Medical University will further enhance Euclid's reputation as the leading provider of Ortho-K lenses in China and throughout Asia."

Through this cooperative agreement, Euclid will support and assist the University in several areas, including the training of new Optometrists and Ophthalmologists in the fitting and use of Orthokeratology lenses, as well as to study of the advantages of Orthokeratology for the prevention of the progression of myopia (nearsightedness) and for treatment for high myopes (extremely nearsighted) patients.  Wenzhou University will support Euclid by presenting at Ophthalmology meetings and conferences, by being a resource for prescribing doctors throughout China, and by promoting the health benefits and care standards for Orthokeratology.  Additionally the University will work with Euclid to open an Ortho-K Trial Center on the hospital grounds as a model for prescribing doctors in China.

About Wenzhou Medical University Eye Hospital.  The Affiliated Eye Hospital of Wenzhou Medical University is a class-A specialized eye hospital and is famous for its " Wenzhou Model" of combination of optometry and ophthalmology.  The eye hospital, the chairman unit of the Chinese Optometry Association, leads the development of optometry in China.  It is also the National Optometry Center of Ministry of Public Health P.R.China and the chairman unit of International Academy Orthokeratology Asia, playing a leading role in the training, discipline development, security monitoring and organization development of Orthokeratology in China.

About Euclid Systems Corporation.  Euclid, founded in 1995, first developed and brought to market a standardized Ortho-K lens design and manufacturing process.  Euclid was the first company to apply for FDA approval, and the Emerald lens was approved by the FDA in 2004.  The Emerald lens has obtained regulatory approval from the appropriate governing bodies in multiple international markets.  Additionally, Euclid is involved in a number of research projects investigating corneal stabilization.

SOURCE Euclid Systems Corporation

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,128.59 +21.89 0.13%
S&P 500 2,000.72 +0.70 0.04%
NASDAQ 4,572.6110 +1.9740 0.04%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs